Vision
The Hyperthermia Focus Group aims to advance the clinical application, research, education, and recognition of hyperthermia (HT) as a valuable and established modality in cancer treatment.

Mission
The mission of the Hyperthermia Focus Group is to serve as a multidisciplinary think tank that brings together clinical, technical, and scientific expertise in hyperthermia. By identifying unmet needs and emerging opportunities, the group fosters collaboration, stimulates innovation, and promotes harmonization and quality improvement in hyperthermia practice. In doing so, the group actively supports ESTRO Councils and Committees in achieving their strategic objectives.

Aims of the Group
The aims of the Hyperthermia Focus Group are:

  1. To enhance the quality, understanding, educational acceptance, and awareness of hyperthermia.

  2. To support national registries and initiatives that improve the quality, consistency, and reporting of hyperthermia treatments.

  3. To provide a central platform for discussion, development, and promotion of clinical trials in hyperthermia.

The activities of the Hyperthermia Focus Group encompass the following areas:

A. Standardization and Quality Assurance

B. Clinical Trials

C. Education, Training, and Awareness

D. Radiobiology and Preclinical Research

Chair:
Sergio Curto
, Physicist, Erasmus MC (NL)

Vice-Chairs:
Hans Crezee
, Physicist, AUMC (NL)
Oliver Riesterer, Radiation Oncologist, Cantonaal Hospital Aarua (CH)
Udo Gaipl, Biologist, Erlangen Universiy Hospital (DE)
Emanuel Stutz, Radiation Oncologist, Inselspital (CH)

Core Members:
Anton Rink
, RT Technician, Young Researcher, Erasmus MC (NL)
Adela Ademaj, Clinician, Young researcher, Cantonaal Hospital Aarua (CH)
Hana Trefna, Physicist, Chalmers Univeristy  (SE)
Jorge Contreras, Radiation Oncologist, Hospital Quiron Malaga (ES)
Laura Ferrera, Radiation Oncologist, University Hospital of Dr Negrin (ES)
Pirus Ghadjar, Radiation Oncologist, Charité - University of Medicine Berlin (DE)
Daphne de Vries-Huizing, Technical Physician, Amsterdam UMC (NL)
Kristyna Olsson Hermanova, Medical Physicist, Proton Therapy Center Czech (CZ)
Tamer Refaat, Radiation Oncologist, Loyola University Chicago (US)
Jeffrey Tuan, Radiation Oncologist, National Cancer Centre Singapore (SG)
Jigna Bhattacharya, Radiation Oncologist, Shubham Cancer centre,Ahmedabad (IN)
Ifigenia  Vasiliadou, Clinical Oncologist, King's College London/Guys Cancer Centre/Royal Marsden Hospital (UK)
Sara Ramela, Radiation Oncologist, Campus Biomedico - Policlinico Universitario (IT)
Aneta Borkowska, Radiation Oncologist, Maria Sklodowska-Curie National Research Institute of Oncology (PL)
Martin Doležel, Radiation Oncologist, University Hospital Olomouc (CZ)

The Hyperthermia Focus Group undertakes the following activities:

A. Standardization and Quality Assurance

  • Develop, publish, and regularly update clinical guidelines, minimum treatment standards, and/or Delphi consensus recommendations.

  • Promote harmonization of treatment delivery and reporting across centers.


B. Clinical Trials

  • Provide a hub where clinical triasl can be preented and discussed.

  • Support the development and initiation of new clinical trials, including coordination of multicenter and prospective studies.

  • Maintain an online overview of active hyperthermia clinical trials with regular updates.

  • Facilitate the integration of hyperthermia into multimodal cancer therapy trials.


C. Education, Training, and Awareness

  • Organize regular educational courses, workshops, and hands‑on training sessions.

  • Promote hyperthermia within ESTRO and other international scientific conferences.

  • Develop educational materials, review articles, and surveys to assess and improve awareness and uptake.


D. Radiobiology and Preclinical Research

  • Support laboratory and translational research to optimize hyperthermia treatment effectiveness.

  • Explore novel combinations with radiotherapy, chemotherapy, and immunotherapy.